TPST
Price:
$1.26
Market Cap:
$5.60M
Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for...[Read more]
Industry
Biotechnology
IPO Date
2012-11-12
Stock Exchange
NASDAQ
Ticker
TPST
According to Tempest Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -82.31% compared to the average of -1.24 of the last 4 quarters.
The mean historical PE Ratio of Tempest Therapeutics, Inc. over the last ten years is -8.00. The current -0.22 PE Ratio has changed 175.00% with respect to the historical average. Over the past ten years (40 quarters), TPST's PE Ratio was at its highest in in the March 2026 quarter at -0.16. The PE Ratio was at its lowest in in the June 2020 quarter at -108.88.
Average
-8.00
Median
-3.29
Minimum
-29.90
Maximum
-0.06
Discovering the peaks and valleys of Tempest Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.30%
Maximum Annual PE Ratio = -0.06
Minimum Annual Increase = -99.27%
Minimum Annual PE Ratio = -29.90
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.45 | -93.73% |
| 2024 | -7.24 | -75.80% |
| 2023 | -29.90 | 7.94% |
| 2022 | -0.37 | -47.32% |
| 2021 | -0.71 | 3.60% |
| 2020 | -0.68 | -97.47% |
| 2019 | -26.95 | 358.29% |
| 2018 | -5.88 | 10.30% |
| 2017 | -0.06 | -99.27% |
| 2016 | -7.77 | -83.46% |
The current PE Ratio of Tempest Therapeutics, Inc. (TPST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.53
5-year avg
-7.73
10-year avg
-8.00
Tempest Therapeutics, Inc.’s PE Ratio is greater than OnKure Therapeutics, Inc. (-0.98), greater than Kezar Life Sciences, Inc. (-1.18), less than FibroGen, Inc. (0.18), greater than Aligos Therapeutics, Inc. (-0.61), greater than Mersana Therapeutics, Inc. (-2.07), greater than Xilio Therapeutics, Inc. (-43.40), greater than PDS Biotechnology Corporation (-1.75), greater than Actinium Pharmaceuticals, Inc. (-1.34), greater than Barinthus Biotherapeutics plc (-0.52), greater than INmune Bio, Inc. (-0.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.98 | $57.43M | |
| -1.18 | $53.86M | |
| 0.18 | $36.69M | |
| -0.61 | $32.67M | |
| -2.07 | $145.36M | |
| -43.40 | $54.64M | |
| -1.75 | $58.61M | |
| -1.34 | $31.69M | |
| -0.52 | $27.41M | |
| -0.79 | $32.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tempest Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tempest Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tempest Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Tempest Therapeutics, Inc. (TPST)?
What is the highest PE Ratio for Tempest Therapeutics, Inc. (TPST)?
What is the 3-year average PE Ratio for Tempest Therapeutics, Inc. (TPST)?
What is the 5-year average PE Ratio for Tempest Therapeutics, Inc. (TPST)?
How does the current PE Ratio for Tempest Therapeutics, Inc. (TPST) compare to its historical average?